| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | GMED | Class A Common Stock | Options Exercise | $863,734 | +13,278 | $65.05 | 13,278 | 21 Nov 2024 | Direct | ||
| transaction | GMED | Class A Common Stock | Sale | $1,128,630 | -13,278 | -100% | $85.00 | 0 | 21 Nov 2024 | Direct | |
| transaction | GMED | Class A Common Stock | Options Exercise | $71,360 | +1,097 | $65.05 | 1,097 | 22 Nov 2024 | Direct | ||
| transaction | GMED | Class A Common Stock | Sale | $93,263 | -1,097 | -100% | $85.02 | 0 | 22 Nov 2024 | Direct | F2 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | GMED | Stock Option (Right to Buy Class A Common Stock) | Options Exercise | $0 | -13,278 | -89% | $0.000000 | 1,722 | 21 Nov 2024 | Class A Common Stock | 13,278 | $65.05 | Direct | F1 |
| transaction | GMED | Stock Option (Right to Buy Class A Common Stock) | Options Exercise | $0 | -1,097 | -64% | $0.000000 | 625 | 22 Nov 2024 | Class A Common Stock | 1,097 | $65.05 | Direct | F1 |
| Id | Content |
|---|---|
| F1 | These options were granted on January 14, 2021 and are fully vested. |
| F2 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $85.00 to $85.08, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4. |